General Information of the Compound
Compound ID
CP0102956
Compound Name
[6-[[5-[[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-1,2-thiazol-3-yl]methyl]pyridin-2-yl]-piperidin-1-ylmethanone
    Show/Hide
Structure
Formula
C25H25N9OS
Molecular Weight
499.604
Canonical SMILES
Cc1cn2c(cnc2c(Nc2cc(Cc3cccc(n3)C(=O)N3CCCCC3)ns2)n1)-c1cn[nH]c1
    Show/Hide
InChI
InChI=1S/C25H25N9OS/c1-16-15-34-21(17-12-27-28-13-17)14-26-24(34)23(29-16)31-22-11-19(32-36-22)10-18-6-5-7-20(30-18)25(35)33-8-3-2-4-9-33/h5-7,11-15H,2-4,8-10H2,1H3,(H,27,28)(H,29,31)
    Show/Hide
InChIKey
BLSODUBGWXTNGZ-UHFFFAOYSA-N
Physicochemical Property
logP
4.23982
Rotatable Bonds
6
Heavy Atom Count
36
Polar Areas
116.99
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
9
Complexity
36

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 145969955
ChEMBL ID
CHEMBL4226704
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01223, Aurora kinase B
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000067 HCT 116 Homo sapiens (Human)  1
1
EC50 = 245 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 < 13 nM